What are CAP and CAP2 studies focused on?

The focus of the CAP and CAP2 studies is specifically on monitoring the adverse events that can arise after Left Atrial Appendage Occlusion (LAAO) procedures. These studies are essential as they provide critical insights into the safety and effectiveness of LAAO therapies in real-world clinical settings. By evaluating the outcomes and potential complications associated with LAAO, these studies help to better understand the risks involved and inform clinical practice regarding patient management following the procedure.

Monitoring adverse events is crucial for improving patient care and outcomes, as it allows for the identification of patterns or issues that may need to be addressed in future procedural techniques or patient selection criteria. Such data contribute significantly to the overall body of evidence needed for clinical decision-making and guideline development in cardiology.